Benitec Biopharma Inc.

NasdaqCM:BNTC Stock Report

Market Cap: US$264.1m

Benitec Biopharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:BNTC Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
24 Dec 24BuyUS$527,174Suvretta Capital Management, LLCCompany47,520US$11.25
03 Dec 24BuyUS$403,200Suvretta Capital Management, LLCCompany42,000US$9.60
20 Nov 24BuyUS$416,616Suvretta Capital Management, LLCCompany41,436US$10.22

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of BNTC?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders1,463,2936.24%
General Public1,465,8726.25%
Institutions9,589,77740.9%
Hedge Funds10,932,53346.6%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 804.6%.

Top Shareholders

Top 25 shareholders own 93.54% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
38.2%
Suvretta Capital Management, LLC
8,960,009US$100.9m1.48%3.5%
12.5%
Franklin Resources, Inc.
2,939,287US$33.1m269%0.01%
11.2%
Janus Henderson Group plc
2,616,427US$29.5m199%0.01%
8.41%
Adage Capital Management, L.P.
1,972,524US$22.2m134%0.04%
5.88%
Steven Oliveira
1,379,235US$15.5m80.5%no data
4.44%
HBM Partners Ltd.
1,041,669US$11.7m23.8%1.21%
3.57%
Nantahala Capital Management, LLC
838,095US$9.4m0%0.62%
2.67%
AWM Investment Company Inc
625,000US$7.0m0%0.8%
1.28%
The Vanguard Group, Inc.
300,021US$3.4m40.8%no data
1.11%
Schonfeld Strategic Advisors LLC
260,417US$2.9m-4.55%0.02%
0.84%
Geode Capital Management, LLC
197,096US$2.2m135%no data
0.74%
BlackRock, Inc.
173,753US$2.0m515%no data
0.65%
GoldenTree Asset Management LP
151,451US$1.7m0%0.13%
0.33%
Simplify Asset Management Inc.
76,337US$859.6k-34.5%0.06%
0.26%
Lion Point Capital, LP
62,000US$698.1k59%3.43%
0.22%
J. Buchi
52,097US$586.6k0%no data
0.21%
MYDA Advisors LLC
50,000US$563.0k0%0.15%
0.18%
Morgan Stanley, Investment Banking and Brokerage Investments
42,367US$477.1k3,100%no data
0.16%
Northern Trust Global Investments
38,200US$430.1k54.2%no data
0.15%
683 Capital Management, LLC
35,817US$403.3k0%0.04%
0.15%
Columbia Management Investment Advisers, LLC
35,476US$399.4k138%no data
0.11%
Megan Boston
25,927US$291.9k0%no data
0.11%
Susquehanna International Group, LLP, Asset Management Arm
24,772US$278.9k0%no data
0.089%
Qube Research & Technologies Ltd
20,896US$235.3k0%no data
0.072%
Corbin Capital Partners, L.P.
16,828US$189.5k0%0.27%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/19 12:49
End of Day Share Price 2025/02/19 00:00
Earnings2024/12/31
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Benitec Biopharma Inc. is covered by 10 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Brian SkorneyBaird
Debjit ChattopadhyayGuggenheim Securities, LLC
Raghuram SelvarajuH.C. Wainwright & Co.